Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors

BACKGROUND: Erythropoietin receptor (EPOR), a member of the cytokine class I receptor family, mediates erythropoietin (EPO)-induced erythroblast proliferation and differentiation, but its significance goes beyond that. The expression and prognosis of EPOR in cancer remain unclear. METHODS: This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yajing, Wang, Senyu, Han, Songtao, Feng, Yangchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963997/
https://www.ncbi.nlm.nih.gov/pubmed/35359375
http://dx.doi.org/10.3389/fonc.2022.844794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963997/
https://www.ncbi.nlm.nih.gov/pubmed/35359375
http://dx.doi.org/10.3389/fonc.2022.844794

Ejemplares similares